This showed CEACAM1 was expressed at significantly increased levels on TFH, TEM, and Th2 cells in the treatment-resistant samples and on Treg cells in both treatment-naive and -resistant tumor samples relative to healthy donor (HD) controls (Fig. 6i). This evidence concerns the gene CEACAM1 and neoplasm.